Don't want ads? Subscribe or login now.

Semler Scientific, Bard To Pay $37M To End FCA Claims

By Sydney Price · September 26, 2025, 9:13 PM EDT

The Department of Justice announced on Friday that two companies have agreed to pay nearly $37 million to resolve claims that they knowingly recommended healthcare providers submit erroneous Medicare claims for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Kane et al v. Semler Scientific, Inc. et al

Case Number

3:16-cv-01516

Court

Florida Middle

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

December 08, 2016

Recent Articles By Sydney

October 10, 2025
ATyr Pharma Faces Investor Suit Over Failed Drug Trial
October 10, 2025
Pharma Co. Escapes Suit Over Ex-CEO's Alleged Misconduct
October 07, 2025
Biogen Says Investors Can't Expand Alzheimer's Drug Suit
September 24, 2025
UnitedHealth Fights Investor Suit Over DOJ's Merger Probe
September 23, 2025
Axsome Settles Investors' Drug Approval Suit For $7.8M
September 10, 2025
DexCom Beats Most Of Investors' Diabetes Device Sales Suit
August 25, 2025
Healthcare Co. Investors Sue Over Contractor's Alleged Fraud
August 22, 2025
Rite Aid Execs Dodge Investor Suit Over Opioid Litigation
August 19, 2025
3D Systems Brass Sued Over Revenue Projections
July 31, 2025
Biotech Co. Beats Investor Suit Over Antifungal Drug Recall